Skip to main content

ADEFOVIR DIPIVOXIL

 ADEFOVIR DIPIVOXIL


BRAND NAME:- ADESERA ,ADEFOVIR 10mg tab.


ADEFOVIR DIPIVOXIL is an anti-hepatitis virus / nonselective antiviral drug and adefovir is a monophosphate analogue of AMP which is active against HBV and some other DNA as well as RNA virus.


ABSORPTION & MECHANISM & PHARMACOLOGICAL ACTIONS:- 


ADEFOVIR is a monophosphate analogue of AMP which is active against HBV and some other DNA 🧬 as well as RNA viruses,but is used only for hepatitis caused by HBV. Esterases in the intestine and liver release the active drug during absorption to attain oral bioavailability of - 60% in terms of adefovir, which is then distributed in whole body water . On entering cells, adefovir is phosphorylated to the diphosphate which has high affinity for HBV DNA polymerase compared to host cell DNA polymerase.

  Ths is enzyme is inhibited and adefovir itself gets incorporated in the viral DNA resulting in termination of the DNA chain . adefovir is primarily excerted by the kidney. While it's plasma t½ is 7 hours , intracellular t½ of the diphosphate is upto 18 hours .

   Adefovir is indicated in chronic hepatitis B , including lamivudine - resistance cases and those having concurrent HIV infection. There is no cross resistance between adefovir and lamivudine. Clinical, biochemical (liver function tests) , histological, serological and virological response occurs in nearly 50% patients within 1 year. 


USED:- In treatment of chronic (HBV ) hepatitis B viruses infection.


DOSE:- 10mg/day 


SIDE EFFECTS:- sore throat, headache, weakness , abdominal pain and flu syndrome. Nephrotoxicity at higher doses, pre-existing renal insufficiency. Lactic acidosis is a risk in patients receiving ANTI- HIV drugs.

Labels:

Comments

Post a Comment

Popular posts from this blog

Cefpodoxime proxetil Uses, Side Effects, and More

 Cefpodoxime proxetil Brand name:- cefoprox ,cepodem,DOXCEF 100,200mg cap.  Cefpodoxime Proxetil is an antibiotic. It kills the bacteria by preventing them from forming the bacterial protective covering (cell wall) which is needed for them to survive. Pharmacodynamic:-  Cefpodoxime is shown to be effective against most Gram positive and Gram negative bacteria, except Pseudomonas aeruginosa, Enterococcus, and Bacteroides fragilis. Mechanism of action:-  Cefpodoxime is active against a wide spectrum of Gram-positive and Gram-negative bacteria. Cefpodoxime is stable in the presence of beta-lactamase enzymes. As a result, many organisms resistant to penicillins and cephalosporins, due to their production of beta-lactamase, may be susceptible to cefpodoxime. Cefpodoxime is inactivated by certain extended spectrum beta-lactamases. The bactericidal activity of cefpodoxime results from its inhibition of cell wall synthesis. The active metabolite of cefpodoxime binds preferentially to penicilli
Post a Comment
Read more

Cephalexin ( ZYD ) ( Cefalexin ) Uses, Side Effects, and More

 Cephalexin (ZYD) (Cefalexin) Brand name:-  Cephacillin 250,500mg cap; Sporidex, Alcephin,Cephaxin cap. Cephalexin (also called Cefalexin)  is the most common used orally effective first generation cephalosporin , similar in spectrum to cefazolin , but less active against penicillinase producing staphylococci and H. Influenza. Plasma protein binding is low; it attains High concentration in bile and is excreted unchanged in urine; t½ - 60min. Pharmacodynamic:-  Cephalexin (also called Cefalexin) is a first generation cephalosporin antibiotic. It is one of the most widely prescribed antibiotics, often used for the treatment of superficial infections that result as complications of minor wounds or lacerations.Label It is effective against most gram-positive bacteria through its inihibition of the cross linking reaction between N-acetyl muramicacid and N-acetylglucosamine in the cell wall, leading to cell lysis. Pharmacokinetics:- Cephalexin is rapidly and almost completely absorbed from t
Post a Comment
Read more

BASILIXIMAB Uses, Side Effects, and More

 BASILIXIMAB BRAND NAME:- Simulect   BASILIXIMAB is another anti CD - 25 antibody with higher affinity for the IL-2 receptor, but shorter plasma t½ (1 week) . is a monoclonal antibody used to prevent rejection in kidney transplants. It is a chimeric mouse-human monoclonal antibody to the α chain (CD25) of the IL-2 receptor of T cells. It is used in combination with other medicines used to prevent organ rejection. PHARMACODYNAMIC:- Basiliximab functions as an IL-2 receptor antagonist. Specifically it inhibits IL-2-mediated activation of lymphocytes, a critical pathway in the cellular immune response involved in allograft rejection.  MECHANISM OF ACTION:-  Basiliximab competes with IL-2 to bind to the alpha chain subunit of the IL2 receptor on the surface of the activated T lymphocytes and thus prevents the receptor from signaling. This prevents T cells from replicating and also from activating B cells, which are responsible for the production of antibodies, which would bind to the trans
1 comment
Read more